SecBot SecBot

ELTP

ELITE PHARMACEUTICALS INC
OTC· Pharmaceutical Preparations· Inc. NJ· CIK 0001053369 Biotech & Drug Discovery
$0.2445 −0.01 (−2.20%)
Oct 26 4:00 PM ET · prev $0.2500
Next earnings
Nov 12
in 17 days
1 year
−60.6%
from $0.6200 · Oct 27
30 days
−2.2%
from $0.2500
52-week range
$0.2200–0.6800
−64% from high · low Oct 5
Avg volume 20D
767.4K
shares / day
Short interest
2.63M
+1.0%
Days to cover
2.2
at average volume
Insider net
+$34.6K
1 buyer · 0 sellers · 12 mo
Filing reports
5
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 12, 2026
Strongest NEUTRAL Elite Pharmaceuticals filed an 8-K announcing that its Q1 FY2027 financial results will be released on…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $34.6K at an average $0.2661. No open-market sales. Price is 8% below their cost.

  • Short sellersSTEADY

    Short interest +1.0% to 2.63M shares. 2.2 days to cover.

  • TrendRANGE

    6% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Sep 30.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 9, 2026 Insider
Dash Barry H bought 100,000 shares
Director @ $0.2598 ($26.0K)
Aug 19, 2026 Insider
Dash Barry H bought 30,000 shares
Director @ $0.2870 ($8.6K)
Aug 12, 2026 Earnings calendar
ELTP Q1 2027 Earnings Scheduled — 2026-08-12
Aug 10, 2026 SEC
Elite Pharmaceuticals filed an 8-K announcing that its Q1 FY2027 financial results will be released on August 13…
8-K — Impact 3/10
Jun 29, 2026 SEC
Elite Pharmaceuticals reported fiscal year 2026 revenue of $148.9M, up 77% YoY, and operating income of $49.1M, up…
8-K — Impact 7/10
Jun 15, 2026 SEC
Elite Pharmaceuticals reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant…
8-K — Impact 5/10
Reddit
Recent posts
r/pennystocks Neutral 27d ago
ELTP at $0.23: What Actually Changed Since 2024 vs now?
1 upvotes · 0 comments
All social signals and their track records

Insider ledger

Form 4
$34.6K
bought · 1 insider
$0
sold · 0 insiders
−8.1%
vs their $0.2661 cost
DateInsiderTypeValue
Oct 9, 2026
Dash Barry H
Director
BUY$26.0K
Aug 19, 2026
Dash Barry H
Director
BUY$8.6K

Earnings setup

Estimates
Nov 12
reports in 17 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
2,632,127
shares short
+1.0%
vs prior settlement
2.2
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
ELTP Q2 2027 Earnings Scheduled — 2026-11-12
Recent
Aug 12, 2026
Earnings date
ELTP Q1 2027 Earnings Scheduled — 2026-08-12
Jun 29, 2026
Earnings date
ELTP Q4 2026 Earnings Scheduled — 2026-06-29

SecBot reports

5 filings · 2 bullish · 0 bearish · 3 neutral
All ELTP filing & press-release reports (5)